- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2019-05-14 15:29:32
- Reporting Period:
- Accepted Time:
- 2019-05-14 15:29:32
- SEC Url:
- Form 4 Filing
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1175151||Cytosorbents Corp||CTSO||Surgical & Medical Instruments & Apparatus (3841)||980373793|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1409212||P. Kathleen Bloch||C/o Cytosorbents Corporation |
7 Deer Park Drive, Suite K
Monmouth Junction NJ 08852
|Chief Financial Officer||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings||Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Common Stock||Acquisiton||2019-05-10||3,000||$6.49||3,000||No||4||P||Indirect||See Footnote|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Remaning Holdings||Nature of Ownership||Explanation|
|Common Stock||9,000||Indirect||See Footnote|
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.4466 to $6.4984, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- These shares were acquired by the reporting person's husband and, as such, the reporting person may be deemed the beneficial owner of such shares.
- Includes (i) the following RSUs that will be settled into common stock upon a "Change In Control" of CytoSorbents Corporation, as defined in the 2014 Long-Term Incentive Plan: (a) 15,700 RSUs granted on February 24, 2017, (b) 47,000 RSUs granted on June 7, 2016, (c) 110,000 RSUs granted on April 8, 2015, and (d) 8,800 RSUs granted on March 15, 2018, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 11,567 RSUs granted on February 28, 2018 and unvested as of the date hereof and (b) 2,714 RSUs granted on March 4, 2019 and unvested as of the date hereof and (iii) 46,944 shares of common stock owned by the reporting person.
- These shares are held by the reporting person's husband in a 401(k) account and as such, the reporting person may be deemed the beneficial owner of such shares.